Abstract
AbstractAfrican nations have struggled to secure lifesaving COVID-19 vaccines, while rich nations have purchased more than they needed, depleting the global supply. High vaccine prices and intellectual property regulations that block the production of cheaper generics have contributed to a condition of African waithood. Hagan examines this waithood, which characterizes the disjuncture between African countries’ existential and humanitarian need for COVID-19 vaccines and corporations’ quest for profits in the pandemic. African waithood, produced by pharmaceutical companies including Moderna and Pfizer, is a direct product of colonialism. Waithood echoes the ongoing colonial relations between African nations and the corporations that continue to exploit them.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
